학술논문
Long‐term safety and efficacy of rIX‐FP prophylaxis with extended dosing intervals up to 21 days in adults/adolescents with hemophilia B
Document Type
Article
Author
Source
In Journal of Thrombosis and Haemostasis May 2020 18(5):1065-1074
Subject
Language
ISSN
1538-7836